hotspot -WSS

hotspot

author：knowledge 2025-09-03 09:18:22 - browse：74

Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024.

Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023. Humana also is “currently assessing the expected impact of emerging utilization trends on its 2024 outlook, which is anticipated to be material if current trends continue,” according to the company’s update to investors.

Humana’s bad news for Wall Street didn’t end there: The company said it appears it only added just 100,000 new Medicare Advantage members from the most recent enrollment period that ended last month — down from estimates that it would enroll anywhere from 325,000 to 435,000 people.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Marvel Studios reveals new trailer for 'The Marvels': Watch here

WSS

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Elizabeth Warren probes abortion access

Caitlin Bernard's story shows physicians can't shy from advocacy

An innovative path out of biotech’s “valley of death”

Some of the ways extreme heat will change life as we know it

TB outbreak tied to bone grafts underscores testing shortcomings

leisure time

hotspot

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

Who are the detained American citizens released from prison in Iran?

Jerome Adams on the need for new antivirals for Covid

CDC overhauls leadership of center that led response to Covid

Medicare details structure of new drug price negotiation program

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

The cancer drug shortage isn’t new — and neither are the solutions

7 of the most gruesome medical devices in history

FDA approval of Sarepta Duchenne genetic therapy gives me hope

HIPAA doesn't protect reproductive records from prosecutors

explore

Where are patients getting their prescriptions for GLP

As Taiwan prepares for anti

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

Maui funeral service workers on devastation of fires: 'I'm in shock'

In new study, freeze

Novo acquires Inversago for up to $1 billion

entertainment

focus

knowledge

focus